What Doctors Want Women to Know About Ozempic and Pregnancy

Health Points

• GLP-1 medications like Ozempic can increase fertility in women with PCOS by restoring ovulation
• These medications may reduce the effectiveness of hormonal birth control pills due to delayed stomach emptying
• Experts recommend stopping GLP-1 drugs two months before trying to conceive and avoiding use during pregnancy

Women taking popular weight-loss medications are discovering unexpected changes that go beyond the scale. Medical experts are now raising important questions about how these drugs interact with reproductive health, from fertility to birth control effectiveness.

GLP-1 receptor agonists—a class of medications that includes Ozempic, Wegovy, and Mounjaro—have transformed weight management for millions. But doctors are finding that these medications affect the body in ways that extend far beyond appetite suppression.

“We’re seeing women who haven’t ovulated in years suddenly become fertile again,”

explains Dr. Maria Henderson, a reproductive endocrinologist at a major fertility clinic.

The fertility connection centers on polycystic ovary syndrome, or PCOS, a hormonal disorder affecting up to 15% of women of childbearing age. PCOS often causes irregular periods, difficulty conceiving, and weight challenges. When women with PCOS lose weight through GLP-1 medications, many experience restored ovulation and increased fertility.

“The weight loss can reset the hormonal balance that PCOS disrupts,”

notes Dr. Sarah Collins, an OB-GYN specializing in reproductive medicine.

This fertility boost presents both opportunities and concerns. Women who weren’t planning pregnancies have found themselves unexpectedly expecting after starting these medications.

The birth control complication adds another layer of complexity. GLP-1 medications slow gastric emptying—the rate at which the stomach processes food and medication. This mechanism contributes to their effectiveness for weight loss by promoting feelings of fullness.

However, that same delayed stomach emptying may interfere with how the body absorbs oral contraceptives. While research is still emerging, medical professionals are advising women to consider backup contraception methods.

“We recommend barrier methods or long-acting reversible contraceptives like IUDs for women on these medications,”

advises Dr. Jennifer Walsh, a family planning specialist.

For women hoping to conceive, the guidance is clear but requires planning. Medical experts recommend discontinuing GLP-1 medications at least two months before attempting pregnancy. This waiting period allows the medication to clear the body’s system completely.

The caution extends throughout pregnancy. Current medical guidance advises against using these medications while pregnant or breastfeeding due to limited safety data. Animal studies have raised concerns about potential developmental effects, though human research remains limited.

“We simply don’t have enough long-term data about these medications in pregnancy,”

states Dr. Rebecca Thompson, a maternal-fetal medicine physician.

Women who discover they’re pregnant while taking GLP-1 medications should contact their healthcare provider immediately. In most cases, doctors recommend stopping the medication and closely monitoring the pregnancy.

The intersection of weight loss, fertility, and reproductive health requires individualized medical guidance. Women with PCOS who desire pregnancy may benefit from the fertility-enhancing effects of these medications, but timing and planning become essential.

For those not planning pregnancy, the potential reduction in birth control effectiveness demands proactive contraceptive strategies. The convenience of a weekly injection doesn’t eliminate the need for comprehensive reproductive health planning.

Medical professionals emphasize the importance of open communication. Women starting GLP-1 medications should discuss their reproductive plans with their healthcare providers, whether they’re hoping to conceive, actively preventing pregnancy, or unsure about future family planning.

The rapid adoption of these medications has outpaced comprehensive research on reproductive effects. As more women of childbearing age use GLP-1 drugs, the medical community continues gathering data and refining recommendations.

For now, awareness and proactive planning remain the best strategies. Understanding how these powerful medications interact with fertility and contraception empowers women to make informed choices about their health.

The broader lesson extends beyond any single medication. As pharmaceutical innovations continue reshaping healthcare, the importance of comprehensive patient education grows. Women deserve complete information about how treatments affect all aspects of their wellbeing, not just the targeted condition.

Healthcare providers are adapting their counseling to address these concerns routinely. Many now include reproductive health discussions as part of the standard conversation when prescribing GLP-1 medications to women of childbearing age.

The evolving understanding of these medications highlights medicine’s dynamic nature. What begins as a diabetes treatment transforms into a weight-loss solution, then reveals unexpected effects on fertility and contraception. Each discovery builds a more complete picture of how these drugs work in the human body.